Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial

Journal of Hepatology

Volumn 35, Issue 3, 2001, Pages 406-411

  Barbaro, Giuseppe ^a,i   Zechini, Franco ^b   Pellicelli, Adriano M ^b   Francavilla, Ruggiero ^c   Scotto, Gaetano ^c   Bacca, Donato ^c   Bruno, Marcello ^d   Babudieri, Sergio ^e   Annese, Mauro ^f   Matarazzo, Filippo ^c   Di Stefano, Gabriele ^g   Barbarini, Giorgio ^h  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c GENERAL HOSPITAL   (Italy)

^d Guadagna Hospital Palermo   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

^f General Hospital   (Italy)

^g Division of Infectious Diseases   (Italy)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ Viale Anicio Gallo 63 ^*  (Italy)

Author keywords

Chronic hepatitis B; Interferon alpha; Lamivudine

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEROCONVERSION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; LAMIVUDINE; MALE; MIDDLE AGED; MUTATION;

EID: 0034843958     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00145-3     Document Type: Article

References (18)

1. The treatment of chronic viral hepatitis
2. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: A meta-analysis
3. A one-year trial of lamivudine for chronic hepatitis B
4. Antiviral therapy for hepatitis B and C in Asians
5. A preliminary trial of lamivudine for chronic hepatitis B infection
6. Lamivudine as initial treatment for chronic hepatitis B in the United States
7. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
8. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial
9. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
10. Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
11. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
12. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
13. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
14. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: A multicenter study
15. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
16. Lamivudine treatment with severely decompensated cirrhosis due to replicating hepatitis B infection
17. Beneficial effect of amivudine in hepatitis B virus-related decompensated cirrhosis